Group for Innovative Cancer TreatmentDivision of Cancer Immunology
The Division of Cancer Immunology aims at identifying novel strategies that can tip the balance to augmenting anti-tumor immune responses by focusing on anti-tumor immune responses and their suppressive mechanisms in a tumor microenvironment. Regulatory T (Treg) cells, actively engaged in the maintenance of immunological self-tolerance and homeostasis, are present in tumor tissues with higher frequencies compared with the periphery and inhibit the development of effective anti-tumor immune responses. We are now investigating the detailed mechanisms of Treg-cell infiltration/proliferation in tumor tissues to control them for a novel target of cancer immunotherapy.
See also Research Summary.
Post-doctoral fellows and graduate school students from Osaka University and Akita University are trained in our Division.